v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Information Related to Statement of Operations

 

   2026   2025   2026   2025 
   Six months ended
June 30,		   Three months ended
June 30,		 
   2026   2025   2026   2025 
                 
Revenue  $222,665   $689,680   $86,346   $129,904 
                     
Operating Expenses:                    
Employee compensation   460,885    599,072    201,731    312,560 
Professional fees   162,204    132,657    55,404    44,757 
Directors fees and expenses   154    227,107    154    107,107 
Marketing and investor relations   56,465    79,002    35,209    48,756 
Insurance**   67,359    91,544    31,243    45,355 
Occupancy costs   39,664    42,132    19,998    20,615 
Credit loss expense   150,000    124,253    150,000    124,253 
Patent costs   54,532    27,117    21,957    15,313 
Stock listing fees   36,250    35,000    18,125    17,500 
Legal fees   96,224    1,070    76,675    1,070 
Depreciation and amortization   289    5,723    145    2,864 
Other operating expenses*   24,572    47,721    16,575    35,772 
Operating expenses   1,148,598    1,412,398    627,216    775,922 
                     
Research and Development Expenses:                    
Employee compensation   81,588    90,643    34,167    43,280 
Insurance**   65,848    89,635    30,612    44,425 
Occupancy costs   118,989    127,796    59,993    63,252 
Depreciation and amortization   342    443    173    223 
Other research and development costs*   7,467    23,446    3,939    17,906 
Research and development expenses   274,234    331,963    128,884    169,086 
                     
Operating Loss  $(1,200,167)  $(1,054,681)  $(669,754)  $(815,104)

 

* Other operating expenses and other research and development expenses consist principally of miscellaneous expenses, each of which is under the Company’s threshold to be separately presented as a significant expense.
   
** Insurance includes all coverage including property, liability, directors’ and officers’ and employees’ medical.